|View printer-friendly version|
Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter 5/80™ for Segmentectomy
During this day-long event in Tubingen,
New advances in lung cancer diagnoses are enabling earlier diagnosis and therefore earlier treatments for patients with lung cancer. Increasingly, segmentectomy rather than a traditional lobectomy is considered as a viable treatment for early-stage lung cancer which preserves more lung tissue than a complete lobectomy.
“The MicroCutter 5/80 is an ideal tool for VATS lobectomy and especially
for segmentectomy as it enables less tissue dissection and allows me to
maneuver more effectively within the patient’s chest,” said PD Dr. Med.
“We believe these courses, where surgeons learn cutting-edge surgical
techniques for VATS procedures, are critically important to demonstrate
how the MicroCutter 5/80’s small size and wider articulation help to
enable adoption of less invasive surgical approaches for these
technically challenging procedures,” said
MicroCutter Indication Information
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.
Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.
The statements in this press release regarding the beneficial use of the
MicroCutter 5/80 during segmentectomy procedures are "forward-looking
statements." There are a number of important factors that could cause
results to differ materially from those indicated by these
forward-looking statements, including the risks detailed from time to
time in Dextera Surgical’s reports filed with the
Dextera Surgical Inc.